Relation between clinicopathological findings and PD-1 or PD-L1 status in non-clear cell renal cell carcinoma by a multicenter study.

被引：0
|
作者：
Matsumoto, Hiroaki
Nagao, Kazuhiro
Samoto, Masahiro
Mori, Junichi
Shimizu, Kosuke
Inoue, Ryo
Yamamoto, Yoshiaki
Yano, Seiji
Hirata, Hiroshi
Shimabukuro, Tomoyuki
Matsuyama, Hideyasu
机构：
[1] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi, Japan
[2] Shuto Gen Hosp, Yanai, Japan
[3] Yamaguchi Univ, Grad Sch Med, Dept Urol, Ube, Yamaguchi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
654
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma
    McKay, Rana R.
    Bosse, Dominick
    Xie, Wanling
    Wankowicz, Stephanie A. M.
    Flaifel, Abdallah
    Brandao, Raphael
    Lalani, Aly-Khan A.
    Martini, Dylan J.
    Wei, Xiao X.
    Braun, David A.
    Van Allen, Eliezer
    Castellano, Daniel
    De Velasco, Guillermo
    Wells, J. Connor
    Heng, Daniel Y.
    Fay, Andre P.
    Schutz, Fabio A.
    Hsu, JoAnn
    Pal, Sumanta K.
    Lee, Jae Lyun
    Hsieh, James J.
    Harshman, Lauren C.
    Signoretti, Sabina
    Motzer, Robert J.
    Feldman, Darren
    Choueiri, Toni K.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2018, 6 (07) : 758 - 765
  • [2] PD-L1 expression in non-clear cell renal cell carcinoma.
    Fay, Andre P.
    Callea, Marcella
    Gray, Kathryn P.
    Thai Huu Ho
    Song, Jiaxi
    Carvo, Ingrid
    Lampron, Megan E.
    Stanton, Melissa L.
    McDermott, David F.
    Atkins, Michael B.
    Freeman, Gordon J.
    Hirsch, Michelle S.
    Signoretti, Sabina
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [3] Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?
    Abbas, Mahmoud
    Steffens, Sandra
    Bellut, Maria
    Becker, Jan U.
    Grosshennig, Anika
    Eggers, Hendrik
    Wegener, Gerd
    Kuczyk, Markus A.
    Kreipe, Hans H.
    Gruenwald, Viktor
    Schrader, Andres J.
    Ivanyi, Philipp
    [J]. MEDICAL ONCOLOGY, 2016, 33 (06)
  • [4] Do programmed death 1 (PD-1) and its ligand (PD-L1) play a role in patients with non-clear cell renal cell carcinoma?
    Mahmoud Abbas
    Sandra Steffens
    Maria Bellut
    Jan U. Becker
    Anika Großhennig
    Hendrik Eggers
    Gerd Wegener
    Markus A. Kuczyk
    Hans H. Kreipe
    Viktor Grünwald
    Andres J. Schrader
    Philipp Ivanyi
    [J]. Medical Oncology, 2016, 33
  • [5] The association between PD-1 / PD-L1 expression and clinicopathological features in sarcomatoid renal cell carcinoma
    Zhao, Yuan
    Shi, Zhongyue
    Xie, Yan
    Li, Ning
    Chen, Hong
    Jin, Mulan
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (01) : 163 - 168
  • [6] Association between PD-L1 Expression and the Prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma
    Chrabanska, Magdalena
    Szweda-Gandor, Nikola
    Rynkiewicz, Magdalena
    Hrabos, Dominik
    Drozdzowska, Bogna
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [7] PD-L1 expression in non-clear cell renal cell carcinoma and benign kidney tumors.
    Fay, Andre Poisl
    Callea, Marcella
    Gray, Kathryn P.
    Ho, Thai Huu
    Song, Jiaxi
    Carvo, Ingrid
    Lampron, Megan E.
    Albiges, Laurence
    Stanton, Melissa L.
    McDermott, David F.
    Atkins, Michael B.
    Freeman, Gordon James
    Hirsch, Michelle S.
    Signoretti, Sabina
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma
    Ueda, Kosuke
    Suekane, Shigetaka
    Kurose, Hirofumi
    Chikui, Katsuaki
    Nakiri, Makoto
    Nishihara, Kiyoaki
    Matsuo, Mitsunori
    Kawahara, Akihiko
    Yano, Hirohisa
    Igawa, Tsukasa
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (11) : 499.e9 - 499.e16
  • [9] Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
    Spirina, Liudmila
    Yurmazov, Zahar
    Usynin, Evgeny
    Kondakova, Irina
    Ladutko, Ekaterine
    Choynzonov, Evgeny
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (02) : 1072 - 1080
  • [10] Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
    Kammerer-Jacquet, Solene-Florence
    Deleuze, Antoine
    Saout, Judikael
    Mathieu, Romain
    Laguerre, Brigitte
    Verhoest, Gregory
    Dugay, Frederic
    Belaud-Rotureau, Marc-Antoine
    Bensalah, Karim
    Rioux-Leclercq, Nathalie
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
12345